UFIS-SWE-IG
0.1.0 - ci-build

UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions

Example Bundle: Norspan-5h-Transderm-SE-BS-MPD-BBDL

Norspan 5 mikrogram/timme depotplåster

MPID: SE-100004434-00021882
EURDID: 459

Full name: Norspan 5 mikrogram/timme depotplåster

- Scientific name part: Norspan

- Strength part: 5 mikrogram/timme

- Pharmaceutical dose form part: Depotplåster

Name usage: Swedish (Kingdom of Sweden)

Authorised dose form: Transdermal patch

Legal status of supply: Medicinal product subject to special medical prescription

Domain: Human use

Resource status: Current

Product classification:

  • 100000097250 buprenorphine

Marketing Authorisation 1 of 1

Authorisation number: 21882

Region: Kingdom of Sweden

Marketing authorisation holder: Mundipharma AB

Identifier:

  • LOC-100002516

Status: Valid (2005-07-01)

Package 1 of 1

PCID:

Description:
Påse, 12 plåster

Marketing status:

  • Kingdom of Sweden: Marketed

Pack size:

  • 12 Patch

Package: 1 Box (Cardboard)

Containing:

Package: 1 Bag (Paper)

Containing: 12 Patch

Manufactured Item

Dose form: Transdermal patch

Unit of presentation: Patch

Ingredient

Role: Active

Substance: Buprenorphine

Presentation strength: 5 microgram(s)/hour / 1 patch

Reference strength:
Buprenorphine 5 microgram(s)/hour / 1 patch

Administrable Product (1 of 1)

Dose form: Transdermal patch

Unit of presentation:

Route of administration:

  • Transdermal use

Ingredients:

Ingredient

Role: Active

Substance: Buprenorphine

Presentation strength: 5 microgram(s)/hour / 1 patch

Reference strength:
Buprenorphine 5 microgram(s)/hour / 1 patch